Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Renal Cancer
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Renal Cancer
    Sorafenib Safe and Effective in Elderly Patients With Metastatic Renal Cell Carcinoma: Presented at EMUC - (DGDispatch)
    Antiangiogenesis Agent Pazopanib Well Tolerated, Offers Clinical Benefits in Patients With Advanced Renal Cell Carcinoma: Presented at EMUC - (DGDispatch)
    Cediranib Demonstrates Safe, Well Tolerated Antitumour Activity in Patients With Advanced Renal Cell Carcinoma: Presented at EMUC - (DGDispatch)
    Interleukin-2 Plus Sorafenib Combination Improves Disease Control Over Sorafenib Alone in Advanced Renal Cell Carcinoma: Presented at EMUC - (DGDispatch)
    TopAbstracts in Renal Cancer 11/25/2009 - (DGNews)

    News archive

     Recent webcasts/CME - Renal Cancer

    Webcasts/CME archive

     Recent cases - Renal Cancer
      Synchronous Lingual and Thyroid Metastasis from Renal Cell Carcinoma
      Granulocytosis and Thrombocytosis in Renal Cell Carcinoma: A Pro-Inflammatory Cytokine Response Originating in the Tumour
      Xp11.2 Translocation Renal Cell Carcinoma Occurring During Pregnancy with a Novel Translocation Involving Chromosome 19: A Case Report with Review of the Literature
      Stauffer's Syndrome as a Prominent Manifestation of Renal Cancer: A Case Report
      Oral Cavity Metastasis of Renal Cell Carcinoma: A Case Report

      Cases archive
        




      my personal edition > renal cancer > news
      divider

        E-Mail this item to a colleague



      TopAbstracts in Renal Cancer 10/28/2009

      10/28/2009

      TopAbstracts™ in Renal Cancer are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide™ newsletter or visited a website Powered by Doctor's Guide™ in the past 14 days. Over 2000 peer-reviewed journals are covered by TopAbstracts.

      TopAbstracts - Past 14 days



      TopAbstracts - Past 3 months




      E-Mail this item to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.